Where does Stephen Bloch work?

Stephen Bloch is CEO & Co-Founder of Allyx Therapeutics, Inc. and General Partner at Canaan Partners and Board director at Liquidia Corporation and Board director at Iantrek.

What check size does Stephen Bloch write?

Stephen Bloch typically writes checks of $250K – $20M.

What companies did Stephen Bloch found?

Stephen Bloch founded Allyx Therapeutics, Inc..

What boards does Stephen Bloch sit on?

Stephen Bloch holds tracked board seats at Ambra Health, Amicus Therapeutics, Corvium, Dicom Grid, Envisia Therapeutics, Genome, Genome Medical Holding Co, Iantrek, Liquidia, Liquidia Corporation.

Where did Stephen Bloch go to school?

Stephen Bloch studied at Massachusetts General Hospital (Diagnostic Radiology Residency and Fellowship); Dartmouth College (AB, History).

Stephen Bloch

InvestorFounder

General Partner at Canaan Partners · Special Advisor at JSD Capital, LLC · Board director at Liquidia Corporation · Board director at Iantrek · CEO & Co-Founder at Allyx Therapeutics, Inc.

Westport, Connecticut

Writes $250K – $20M checks · typically $10M

FoundedAllyx Therapeutics, Inc.

Find your path to Stephen

190 people in our graph share verified history with Stephen — schools, employers, funds. One of them is your warm intro.

Brad WeirickunlockedStephen: together at Dartmouth College (1980–1982)

×3Stephen: together at Canaan Partners

×2Stephen: together at Dartmouth College

×3Stephen: together at Arthur D. Little

About

Stephen Bloch is a former physician and 20+ year healthcare investor across biopharma, medtech, and digital health who combines General Partner experience with running EvolveImmune Therapeutics as an active operator-investor.

Contact· self-published, not guessed

s•••@canaan.comreveal

Invests in

BiotechConsumerDeep TechDigital HealthEnterprise SoftwareFintechHardwareHealthtechMedical Devices

Beyond investing

Founded: Stephen Bloch helped found and manage Radiology Management Sciences (RMS), OmniSonics Medical Technologies, and TeleRad.
Boards: Stephen Bloch is a member of Dartmouth Medical School's Board of Advisors.
More: Stephen Bloch is a former practicing physician.

From published sources — common ground for a warm intro.

Board director at Liquidia Corporation

Intro paths

→

In turn, Stephen can intro founders to Liquidia Corporation's investors below.

Liquidia Corporation's investors · 3

Canaan PartnersStamford · $500K – $20M checks · since 2021 New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2021 PBM CapitalCharlottesville · since 2021

Board director at Iantrek

Intro paths

→

In turn, Stephen can intro founders to Iantrek's investors below.

Iantrek's investors · 7

aMoonRa'anana Canaan PartnersStamford · $500K – $20M checks · since 2020 Civilization Ventures Management, LlcTiburon · $1M – $10M checks FemHealth VenturesShort Hills JSD Capital, LLCNew York · $10M checks US Venture PartnersMenlo Park · $500K – $10M checks · since 2025 Visionary VenturesNewport Beach · $5M – $15M checks

Co-founders at Iantrek

Tsontcho IanchulevExecutive Officer, Director

Sean IanchulevFounder & Chairman of the Board (CMO)

CEO & Co-Founder at Allyx Therapeutics, Inc.

Intro paths

→

In turn, Stephen can intro founders to Allyx Therapeutics, Inc.'s investors below.

Allyx Therapeutics, Inc.'s investors · 5

Connecticut InnovationsNew Haven · $500K – $2M checks Elm Street VenturesNew Haven · $250K – $1M checks National Institutes of Health (NIH)since 2020 Spring Mountain CapitalNew York WHINNew York · since 2026

Co-founders at Allyx Therapeutics, Inc.

Paul FonteyneCo-Founder

Stephen StrittmatterScientific Founder

Timothy SiegertCOO, Co-Founder

Tim Siegert, PhDCOO & Co-Founder

Experience

BiotechnologyChief Executive Officercurrent2019 — presentNew Haven County, Connecticut, United States
EvolveImmune TherapeuticsChief Executive Officercurrent2019 — presentNew Haven, CT
Allyx Therapeutics, Inc.Chief Executive Officercurrent2019 — presentNew Haven, CT
Canaan PartnersGeneral Partnercurrent2002 — presentWestport, CT
Liquidia CorporationChairman Of The Boardcurrent2018 — present
Radiology Management SciencesChief Executive Officer1995 — 2002Cambridge, MA
Arthur D. Littleconsultant1994 — 1995

Skills & more

Venture Capital39Start-ups24

From Stephen's professional profile.

Deals · 7

Liquidia CorporationBoard seat

via Canaan Partners · filed Apr 2021 · $21.7M raise

IantrekBoard seat

via Canaan Partners · filed Oct 2020 · $5.2M raise

Liquidia TechnologiesBoard seat

via Canaan Partners · filed Jan 2020 · $22.4M raise

Genome Medical Holding CoBoard seat

via Canaan Partners · filed Aug 2018 · $223.2K raise

Dicom GridBoard seat

via Canaan Partners · filed Nov 2017 · $7.4M raise

TruverisBoard seat

via Canaan Partners · filed Aug 2017 · $34.7M raise

Envisia TherapeuticsBoard seat

via Canaan Partners · filed Oct 2015 · $5.1M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Ambra Health Amicus TherapeuticsCorviumGenomeLiquidiaMarinus Pharmaceuticals Onkos Surgical Onkos Surgical

Investor

Advanced BioHealingAmbra Health Amicus TherapeuticsEnvisiaMarinus Pharmaceuticals

Sources: curated public sources · SEC Form D filings · the firm's website.

Colleagues at Canaan Partners

Antonio Lepore

Investor at Canaan Partners

Brendan Dickinson

General Partner at Canaan Partners

Brent Ahrens

General Partner at Canaan Partners

Bridget Flaherty

Director of Primary Labs at Primary Venture Partners

Colleen Cuffaro

Partner at Canaan Partners

Dana Malman Warren

Investor at Canaan Partners

Deepak Kamra

General Partner at Canaan Partners

Evan Teiger

Investor at Canaan Partners

Network1

Eric Linsley

Managing Partner at BioInnovation Capital

Investors connected to Stephen in public investor directories — a warm-intro map.

Frequently asked questions

Who is Stephen Bloch?: Stephen Bloch is a former physician and 20+ year healthcare investor across biopharma, medtech, and digital health who combines General Partner experience with running EvolveImmune Therapeutics as an active operator-investor.
Where does Stephen Bloch work?: Stephen Bloch is CEO & Co-Founder of Allyx Therapeutics, Inc. and General Partner at Canaan Partners and Board director at Liquidia Corporation and Board director at Iantrek.
What does Stephen Bloch invest in?: Stephen Bloch invests in Biotech, Consumer, Deep Tech, Digital Health, Enterprise Software, Fintech, Hardware, Healthtech, Medical Devices.
What check size does Stephen Bloch write?: Stephen Bloch typically writes checks of $250K – $20M.
What companies did Stephen Bloch found?: Stephen Bloch founded Allyx Therapeutics, Inc..
What boards does Stephen Bloch sit on?: Stephen Bloch holds tracked board seats at Ambra Health, Amicus Therapeutics, Corvium, Dicom Grid, Envisia Therapeutics, Genome, Genome Medical Holding Co, Iantrek, Liquidia, Liquidia Corporation.
What companies has Stephen Bloch invested in?: Investments tracked here include Advanced BioHealing, Ambra Health, Amicus Therapeutics, Envisia, Liquidia Corporation, Marinus Pharmaceuticals.
Where did Stephen Bloch go to school?: Stephen Bloch studied at Massachusetts General Hospital (Diagnostic Radiology Residency and Fellowship); Dartmouth College (AB, History).